Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways

Hosford SR, Miller TW

Pharmacogenomics and Personalized Medicine 2014, 7:203-215

Published Date: 6 August 2014